Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.
$225.03M net income for the year ended January 3, 2026. These are reported results, not a forecast or a stock recommendation.
Latest-filed standard financial facts · USD
Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.
Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.
| Reported period | Reported value | Filed | Source |
|---|---|---|---|
| December 29, 2024 – January 3, 2026 | $2,433,199,000 | March 19, 2026 | 10-K ↗ |
| December 31, 2023 – December 28, 2024 | $2,024,506,000 | March 19, 2026 | 10-K ↗ |
| January 1, 2023 – December 30, 2023 | $1,895,209,000 | March 13, 2025 | 10-K ↗ |
| January 2, 2022 – December 31, 2022 | $1,787,645,000 | March 14, 2024 | 10-K ↗ |
| January 3, 2021 – January 1, 2022 | $1,678,618,000 | March 16, 2023 | 10-K ↗ |
| December 29, 2019 – January 2, 2021 | $1,495,105,000 | March 28, 2022 | 10-K ↗ |
| December 30, 2018 – December 28, 2019 | $1,384,065,000 | March 28, 2022 | 10-K ↗ |
One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.
Concept: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · Retrieved October 11, 2026
Response SHA-256: 582a7816d030cf3b9b3624b0298324a2aeb80a93bdc93666926788ed82d3cbf0
Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.